Study on OsseoSpeed™ TX Narrow Implants in the Upper Jaw in a Chinese Population

October 8, 2019 updated by: Dentsply Sirona Implants and Consumables

An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Maxilla. A 3-years Follow-up Study.

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 3mm diameter implant in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the 3 mm implant is a safe and predictable procedure.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Shanghai, China
        • Tong Ji University, Oral Implants Department
      • Wuhan, China, 430079
        • School of Stomatology Wuhan University
      • Xi'an, China, 710032
        • Dept. of Oral Implants, School of Stomatology, Fourth Military Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  1. Provision of informed consent
  2. Aged 20-75 years at enrollment
  3. History of edentulism in the study area of at least two months
  4. Neighboring tooth/teeth to the planned crown(s) must have natural root(s)
  5. Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned crowns
  6. Deemed by the investigator to have a bone height and width suitable for 3.0 mm diameter study implant
  7. Deemed by the investigator as likely to present an initially stable implant situation

Exclusion Criteria:

  1. Unlikely to be able to comply with study procedures, as judged by the investigator
  2. Uncontrolled pathologic processes in the oral cavity
  3. Known or suspected current malignancy
  4. History of radiation therapy in the head and neck region
  5. History of chemotherapy within 5 years prior to surgery
  6. Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration, as deemed by the investigator
  7. Uncontrolled diabetes mellitus
  8. Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
  9. Smoking more than 10 cigarettes per day
  10. Present alcohol and/or drug abuse
  11. Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
  12. Previous enrollment in the present study
  13. Simultaneous participation in another clinical study, or participation in a clinical study during the last weeks prior to enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: OsseoSpeed™ TX
OsseoSpeed™ TX narrow implants (diameter 3 mm) of lengths 11-15 mm
OsseoSpeed™ TX narrow implants (diameter 3 mm) of lengths 11-15 mm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant Survival
Time Frame: Measured at the 3-year follow-up visit after implant loading.
Implant survival rate evaluated clinically and radiographically.
Measured at the 3-year follow-up visit after implant loading.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant Stability
Time Frame: Measured at the 3-year follow-up visit after implant loading.
Implant stability evaluated clinically/manually (recorded as stable yes/no).
Measured at the 3-year follow-up visit after implant loading.
Marginal Bone Level Alteration
Time Frame: Measured at the 3-year follow-up visit after implant loading.

Marginal Bone Level (mm) determined from radiographs and expressed as a difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.

Marginal Bone Level expressed in millimeters obtained at the 3-year follow-up visit compared to values obtained at delivery of the temporary restoration i.e. loading (baseline).

Measured at the 3-year follow-up visit after implant loading.
Condition of the Periimplant Mucosa by Assessment of Probing Pocket Depth (PPD).
Time Frame: Measured at implant loading and at the 3-year follow-up visit after loading.

Change in pocket depth expressed in millimeters at time of the 3 years follow-up visit, compared to values obtained at delivery of permanent restoration, i.e. loading (baseline).

Negative value = increased pocket depth.

Measured at implant loading and at the 3-year follow-up visit after loading.
Condition of the Periimplant Mucosa by Assessment of Bleeding on Probing (BoP).
Time Frame: Measured at implant loading and at the 3-year follow-up visit after loading.
Condition of the periimplant mucosa by assessment of Bleeding on Probing (BoP). Presented as % of implants that show presence of bleeding on probing at time of the 3-year follow-up visit.
Measured at implant loading and at the 3-year follow-up visit after loading.
Presence of Plaque
Time Frame: Measured at the 3-year follow-up visit after implant loading.
Occurence of plaque around the study implant. Presented as proportion of implants that show presence of plaque at time of the 3-year follow-up visit.
Measured at the 3-year follow-up visit after implant loading.
Gingival Zenith Score
Time Frame: Measured at implant loading and at the 3-year follow-up visit after loading.

Gingival zenith score measured from the gingival zenith to the incisal edge of the prosthetic crown with a periodontal probe to nearest 0.5 mm.

Presented as change from loading of permanent restoration to time of the 3-year follow-up visit.

Measured at implant loading and at the 3-year follow-up visit after loading.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Li Dehua, Prof, Dept. of Oral Implants, School of Stomatology, Fourth Military Medical University, Xi'an

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2011

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

July 6, 2011

First Submitted That Met QC Criteria

July 7, 2011

First Posted (Estimate)

July 8, 2011

Study Record Updates

Last Update Posted (Actual)

October 15, 2019

Last Update Submitted That Met QC Criteria

October 8, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Partially Edentulous Jaw

Clinical Trials on OsseoSpeed™ TX

3
Subscribe